Gelteq Limited Ordinary Shares (GELS)
Gelteq Limited Ordinary Shares at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Gelteq Limited Ordinary Shares (GELS) is a Drug Manufacturers - Specialty & Generic company based in AU with a market capitalization of $4.1M. Free cash flow was negative at -$4.3M. This page tracks GELS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
AU · 7 employees · IPO Oct 29, 2024
Valuation
Valuation & price
$0.43as of May 26, 2026· -77.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.1M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$4.3M
Free cash flow (USD)
$3.9M
Net debt
0.0%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2020 → 2025
Free cash flow by year
2020 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 6-K filed Jun 30, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Gelteq Limited Ordinary Shares's market cap?
Gelteq Limited Ordinary Shares (GELS) has a market capitalization of $4.1M.
What is GELS's P/E ratio?
A meaningful P/E ratio is not available for GELS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying GELS stock?
SEC Form 4 filings show no open-market insider buys at Gelteq Limited Ordinary Shares in the last 90 days (0 sells).
Same arena
Related companies in Drug Manufacturers - Specialty & Generic
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.